Overall, these findings could contribute to improve the potential utility of invasiveness biomarkers, beside the role of mesothelin, osteopontin, fibulin-3, hyaluronic acid, VEGF, and MPF in the diagnosis and prognosis of MM [49]. This evidence concerns the gene EFEMP1 and Miyoshi myopathy.